Adam Schoen, Partner, Brown Rudnick
Adam Schoen advises life science and medical device companies regarding implementation of a patent strategy to further business objectives and business goals. Adam’s practice encompasses patent preparation and prosecution, portfolio development, product clearance, freedom to operate analysis and intellectual property due diligence. Adam works with public and private companies, investors, and academic institutions.
Adam has experience with a variety of technologies, such as next generation sequencing technologies, droplet based technologies, cancer diagnostics, medical device technology (ophthalmology, cardiology, orthopedics, neurology, spine) and medical imaging technology (IVUS and OCT), mass spectrometry, small molecule therapeutics, digital health, near field communication technology, and semiconductor technology. He manages patent portfolios of all sizes and develops strategies to maximize and protect intellectual property rights in both the United States and foreign jurisdictions.
Prior to law school, Adam was a scientist of analytical chemistry for ArQule Inc., a combinatorial chemistry and drug discovery company.
Liz Kislik: Conflict Managed
Jay Johnson: Behavioral Intelligence
Lindy Fishburne: “Break Out” Into a New Space
Arvind Rajan: Transformative Care
Frank Dobbin: Commitment to Change
Guy Friedman: Building Trust
Lorin Gu: Problem Solvers With Capital
Nada Hanafi: See It, Believe It
Maureen Shaffer: How to Tell Your Story
Manav Sevak: The Care in Care Delivery
Kyle Kiser: A Tough Pill to Swallow
Julie Wroblewski: Investing in the Future
Rajit Kamal: Leading with Vulnerability
Prentice Tom: Sounds of Mental Illness
Anne Tumlinson: Step Off the Cliff
Marcus Whitney: Orchestrating Change
John Kao: The Servant Leader
Nagraj Kashyap: Art, Not Science
Vivian Lee: We Are All Unique
Mike Snyder: The System is Broken
Create your
podcast in
minutes
It is Free
The emPOWERed Half Hour
NABOR® TALKS
U.S Property Podcast
Aligned Money Show
The Ramsey Show
Planet Money